CVE-2022-2095 Information disclosure in GitLab
An authenticated user can view public fingerprints and names of deploy keys with write permissions on public projects, exposing sensitive metadata.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- Available
What is CVE-2022-2095?
CVE-2022-2095 is a medium-severity vulnerability in Gitlab Gitlab, published on 5 Aug 2022. Any signed-in user can exploit it over the network, with no action from the victim.
Official description
An improper access control check in GitLab CE/EE affecting all versions starting from 13.7 before 15.0.5, all versions starting from 15.1 before 15.1.4, all versions starting from 15.2 before 15.2.1 allows a malicious authenticated user to view a public project's Deploy Key's public fingerprint and name when that key has write permission. Note that GitLab never asks for nor stores the private key.
Weakness: CWE-863
Which versions are affected by CVE-2022-2095?
1 open source package ship an affected version, including gitlab. It affects 1 product.
| Package | Affected | Fixed in |
|---|---|---|
gitlab Bitnami | From 13.7.0 | 15.0.5, 15.1.4, 15.2.1 |
Products include Gitlab Gitlab.
How do I fix CVE-2022-2095?
Upgrade gitlab to a fixed version for your release line: 15.0.5, 15.1.4 or 15.2.1.
Is CVE-2022-2095 being exploited?
There is no known exploitation of CVE-2022-2095 in the wild and no public exploit code.
Other vulnerabilities in Gitlab Gitlab
- CVE-2026-97229 GitLab Community Edition and Enterprise Edition Integer Overflow or Wraparound
- CVE-2026-85706 GitLab Community Edition and Enterprise Edition Path Traversal
- CVE-2023-7028 GitLab Community and Enterprise Editions Improper Access Control
- CVE-2021-22205 GitLab Community and Enterprise Editions Remote Code Execution
- CVE-2021-39935 GitLab Community and Enterprise Editions Server-Side Request Forgery (SSRF)
Sources
Also known as BIT-gitlab-2022-2095, GHSA-hjx6-96hg-jf7x, UBUNTU-CVE-2022-2095.